Skip to content

Drug interactions

Insulin neutral human-insulin isophane protamine human + Rosiglitazone

Severity: Major

Insulin neutral human-insulin isophane protamine human and Rosiglitazone: major interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Rosiglitazone enhances insulin sensitivity and adds to the glucose-lowering effect of insulin, increasing hypoglycemia risk. Combined use also raises the risk of fluid retention and heart failure, and labeling advises against routine use with insulin.

What this interaction means in plain words

Insulin neutral human-insulin isophane protamine human and Rosiglitazone can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.

Insulin neutral human-insulin isophane protamine human belongs to Endocrine; Rosiglitazone belongs to Endocrine.

Evidence level: High

Why it happens

Additive glucose lowering via insulin sensitization plus exogenous insulin, with PPAR-gamma mediated fluid retention.

What to do

Avoid the combination where possible; if used, monitor glucose closely and reduce the insulin dose as needed. Assess for edema, rapid weight gain and heart failure signs.

What to ask your pharmacist

  • Does the benefit of taking both outweigh the risk in my case?
  • Do I need any blood test, ECG or other check while on both?
  • What early warning signs should I watch for, and what should I do if they appear?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Insulin neutral human-insulin isophane protamine human and Rosiglitazone, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Insulin neutral human-insulin isophane protamine human with Rosiglitazone?

MediHelp rates the interaction as major. Insulin neutral human-insulin isophane protamine human and Rosiglitazone can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Rosiglitazone enhances insulin sensitivity and adds to the glucose-lowering effect of insulin, increasing hypoglycemia risk. Combined use also raises the risk of fluid retention and heart failure, and labeling advises against routine use with insulin.

How serious is the interaction between Insulin neutral human-insulin isophane protamine human and Rosiglitazone?

MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid the combination where possible; if used, monitor glucose closely and reduce the insulin dose as needed. Assess for edema, rapid weight gain and heart failure signs.

What other medicines interact with Insulin neutral human-insulin isophane protamine human?

MediHelp also lists interactions of Insulin neutral human-insulin isophane protamine human with, for example, Ethanol, Pentamidine, Acarbose. The full list is on the Insulin neutral human-insulin isophane protamine human page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in